Daiichi Sankyo (OTCMKTS:DSNKY) Sees Unusually-High Trading Volume – Here’s Why

by · The Markets Daily

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY – Get Free Report) saw unusually-high trading volume on Thursday . Approximately 728,887 shares were traded during mid-day trading, an increase of 79% from the previous session’s volume of 406,267 shares.The stock last traded at $19.10 and had previously closed at $19.04.

Analyst Upgrades and Downgrades

Separately, Zacks Research cut Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 19th. One analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Check Out Our Latest Research Report on Daiichi Sankyo

Daiichi Sankyo Stock Up 1.4%

The business has a fifty day moving average of $21.99 and a 200 day moving average of $23.57. The company has a current ratio of 2.31, a quick ratio of 1.60 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $36.59 billion and a PE ratio of 18.22.

Daiichi Sankyo Company Profile

(Get Free Report)

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.

Read More